Scientific Sessions 2025  /  Forgotten No More: The Current Belle of the Ball? Breakthrough Evolutions in Hypertrophic Cardiomyopathy  /  Gene Therapy: The Next Frontier or Fool's Gold?
Logo

American Heart Association

  45
  0

Final ID:

Gene Therapy: The Next Frontier or Fool's Gold?

  • Seidman, Christine  ( HARVARD MEDICAL SCHOOL , Boston , Massachusetts , United States )
  • Watkins, Hugh  ( UNIVERSITY OXFORD , Oxford , United Kingdom )
    • Author Disclosures:
    Christine Seidman: DO have relevant financial relationships ; Other (please indicate in the box next to the company name):Merck, Board of Directors:Active (exists now) ; Advisor:Tenaya:Active (exists now) ; Advisor:Maze:Past (completed) | Hugh Watkins: No Answer
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Forgotten No More: The Current Belle of the Ball? Breakthrough Evolutions in Hypertrophic Cardiomyopathy

Saturday, 11/08/2025 , 09:45AM - 11:00AM

Main Event

More abstracts on this topic:
TN-201, an Investigational MYBPC3 Gene Replacement Therapy: Interim Clinical Data from MyPEAK-1, a Phase Ib/2a Study Evaluating Safety and Early Efficacy of TN-201 in Adult Patients with MYBPC3-Associated Hypertrophic Cardiomyopathy

Desai Milind, Paterson Natasha, Ivey Kathy, Tingley Whittemore, Nagueh Sherif, Giudicessi John, Pollman Matt, Varfaj Bardha, Harrison William, Lombardi Laura, Argast Gretchen, Tomlinson Latanya

Cardiac Myosin Inhibitors in HCM - Altering The Natural History or Am I Delusional?

Owens Anjali, Olivotto Iacopo

More abstracts from these authors:
So How Do We Determine the Right Strategy for the Right Patient?

Watkins Hugh, Seidman Christine

Treating cardiovascular disease with Base and Prime Editing

Seidman Christine, Steinmetz Lars, Olson Eric

You have to be authorized to contact abstract author. Please, Login
Not Available